XML 69 R54.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Quarterly Results of Operations (unaudited) (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Quarterly Financial Data [Abstract] |
Unaudited consolidated quarterly results of operations | The unaudited consolidated quarterly results of operations (in thousands, except per share data) were as follows:
| For the Three Months Ended
| December 31 |  | September 30 |  | June 30 |  | March 31
2021 |  |  |  |  |  |  |
Total revenue | $ | 248,358 |  |  | $ | 222,471 |  |  | $ | 222,057 |  |  | $ | 215,071 |
Total operating expenses | 260,572 |  | 229,052 |  | 229,728 |  | 231,016
Net loss from continuing operations | 3,053 |  | (13,040) |  | (9,107) |  | (11,190)
Net income (loss) from discontinued operations, net of tax | (8,700) |  | — |  |  | — |  |  | 1,383
Net loss attributable to common shareholders of Evolent Health, Inc. | (5,647) |  | (13,040) |  | (9,107) |  | (9,807)
Income (loss) per common share |  |  |  |  |  |  |
Basic and diluted |  |  |  |  |  |  |
Continuing operations | $ | 0.03 |  |  | $ | (0.15) |  |  | $ | (0.11) |  |  | $ | (0.13) |
Discontinued operations | (0.09) |  |  | — |  |  | — |  |  | 0.01 |
2020 |  |  |  |  |  |  |
Total revenue | $ | 246,536 |  |  | $ | 239,572 |  |  | $ | 217,299 |  |  | $ | 221,232 |
Total operating expenses | 246,804 |  | 256,020 |  | 443,128 |  | 246,323
Net loss from continuing operations | (10,637) |  | (37,035) |  | (202,013) |  | (78,487)
Net loss from discontinued operations, net of tax | (3,166) |  | (1,135) |  | (1,508) |  | (265)
Net income (loss) attributable to non-controlling interests | 822 |  | (822) |  | — |  |  | — |
Net loss attributable to common shareholders of Evolent Health, Inc. | (14,625) |  | (37,348) |  | (203,521) |  | (78,752)
Loss per common share |  |  |  |  |  |  |
Basic and diluted |  |  |  |  |  |  |
Continuing operations | $ | (0.13) |  |  | $ | (0.43) |  |  | $ | (2.37) |  |  | $ | (0.93) |
Discontinued operations | (0.04) |  | (0.01) |  | (0.01) |  | — |

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialDataAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=124502072&loc=d3e1280-108306 + Details
Name: | us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration